Document is current
Any future updates will be listed below
-
Authors
Tsoi, Ho
Leung, George Man Hong
Man, Ellen Pui Sum
You, Chan Ping
Cheung, Koei Ho Lam
Chan, Kelvin Yuen Kwong
Gong, Chun
Huen, Michael Shing Yan
Khoo, Ui Soon https://orcid.org/0000-0003-2200-7505
-
Funding
Funding for this research was provided by:
Innovation and Technology Commission (ITS/069/16)
Health and Medical Research Fund (04151826, 07182026)
University Research Committee, University of Hong Kong (20191016002, 202111160035, 202111159194, 2022100846)
Research Grants Council, University Grants Committee (17106824)
- License Information
-
More Information
Article History
Received: 11 April 2025
Accepted: 21 July 2025
First Online: 5 August 2025
Declarations
:
: The procedures on mice were reviewed and approved by Committee on the Use of Live Animals in Teaching and Research, The University of Hong Kong (5236-19). Approval was granted from The Institutional Review Board of the University of Hong Kong/Hospital Authority Hong Kong West Cluster (HKU/HA HKW IRB No. UW 16–391) for collecting human tissue and blood samples.
: Not applicable.
: USK, HT, and CG are the inventors of the patent (Use of HCN Inhibitors for Treatment of Cancer; EP3615052B1). The other authors declare that they have no competing interests.
